Valuation: Tempus AI, Inc.

Market Cap 12.99B 11.6B 10.83B 9.83B 18.52B 1,256B 18.66B 130B 50.83B 639B 48.76B 47.7B 2,054B P/E 2026 *
-51.7x
P/E 2027 * -55.2x
Enterprise Value 13.59B 12.14B 11.33B 10.29B 19.37B 1,314B 19.52B 136B 53.17B 668B 51B 49.9B 2,149B EV / Sales 2026 *
8.52x
EV / Sales 2027 * 6.86x
Free-Float
61.4%
Yield 2026 *
-
Yield 2027 * -
1 day-10.62%
1 week-11.99%
Current month-12.48%
1 month+9.36%
3 months+20.42%
6 months+53.71%
Current year+4.56%
1 week 6.3
Extreme 6.3
7.6
1 month 5.07
Extreme 5.07
7.67
Current year 3.48
Extreme 3.485
7.67
1 year 3.48
Extreme 3.485
7.67
3 years 3.48
Extreme 3.485
7.67
5 years 3.48
Extreme 3.485
7.67
10 years 3.48
Extreme 3.485
7.67
Manager TitleAgeSince
Chief Executive Officer 56 2015-07-31
Director of Finance/CFO 40 2017-07-31
Chief Administrative Officer 55 2020-05-31
Director TitleAgeSince
Chairman 56 2015-07-31
Director/Board Member 53 2019-10-28
Director/Board Member 74 2017-08-31
Change 5-day change 1-year change 3-year change Capi.($)
-10.62%-11.99% - - 12.99B
+4.16%+4.16%+49.37%+94.17% 74.69B
+0.46%-1.16%+23.36%+79.34% 58.81B
+0.17%-1.16%+3.59%+34.55% 48.45B
+0.50%-2.14%+331.33%+688.65% 42.84B
-0.72%-3.99%+28.50%+29.35% 42.79B
+0.34%-0.52%+6.56%+110.67% 41.25B
-0.11%+1.96%+9.19%+52.66% 31.13B
-2.07%+1.16%+35.00%+26.28% 30.28B
-0.50%-3.10%-10.19%-12.86% 24.05B
Average -1.01%-0.25%+52.97%+122.53% 43.81B
Weighted average by Cap. +0.18%-0.54%+55.85%+128.90%

Financials

2026 *2027 *
Net sales 1.6B 1.43B 1.33B 1.21B 2.27B 154B 2.29B 15.98B 6.24B 78.48B 5.99B 5.86B 252B 1.97B 1.76B 1.64B 1.49B 2.8B 190B 2.83B 19.7B 7.7B 96.75B 7.38B 7.22B 311B
Net income -246M -220M -205M -186M -351M -23.79B -353M -2.46B -962M -12.1B -923M -903M -38.89B -236M -211M -197M -179M -337M -22.86B -340M -2.37B -925M -11.63B -887M -868M -37.37B
Net Debt 598M 534M 499M 453M 853M 57.86B 859M 5.99B 2.34B 29.43B 2.25B 2.2B 94.6B 496M 443M 414M 376M 708M 48.01B 713M 4.97B 1.94B 24.42B 1.86B 1.82B 78.49B
Projected Income Statement - Annual - Tempus AI, Inc.
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change Volume
26-10-06 US$6.310 -10.62% 2,915
26-10-05 US$7.060 +5.69% 24
26-10-02 US$6.680 -1.62% 4
26-10-01 US$6.790 -5.83% 737
26-09-30 US$7.210 +0.56% 297
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Tempus AI, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
71.98USD
Average target price
70.61USD
Spread / Average Target
-1.90%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tempus AI, Inc.